← Back to ACS BrightEdge Profile
ACS BrightEdge focuses on early-stage investments.
ACS BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society.
Focusing on early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.
Primarily early-stage investments.
HealthTech, Biotech, Oncology, Pharmacology, Philanthropy, Fundraising.
Cancer-focused therapeutics, diagnostics, devices, and technologies.
ACS BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, focusing on early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and technologies.
ACS BrightEdge is located in Kennesaw, United States.
This information is not publicly available.
ACS BrightEdge is a Corporate VC and VC Firm.
Yes, ACS BrightEdge invests in HealthTech.
Yes, ACS BrightEdge invests in Biotech.
Verification Confidence: 92% | Source: investment_thesis | Entity: ACS BrightEdge